Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

I-131 uptake in the breast from fat necrosis.

Hoang JT, Weissenborn MR, Spigel JJ, Welch BJ, Grossman SJ.

Proc (Bayl Univ Med Cent). 2019 Feb 6;32(1):140-142. doi: 10.1080/08998280.2018.1519496. eCollection 2019 Jan.

2.

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor.

Martinez Botella G, Salituro FG, Harrison BL, Beresis RT, Bai Z, Blanco MJ, Belfort GM, Dai J, Loya CM, Ackley MA, Althaus AL, Grossman SJ, Hoffmann E, Doherty JJ, Robichaud AJ.

J Med Chem. 2017 Sep 28;60(18):7810-7819. doi: 10.1021/acs.jmedchem.7b00846. Epub 2017 Aug 17.

PMID:
28753313
3.

Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21.

Martinez Botella G, Salituro FG, Harrison BL, Beresis RT, Bai Z, Shen K, Belfort GM, Loya CM, Ackley MA, Grossman SJ, Hoffmann E, Jia S, Wang J, Doherty JJ, Robichaud AJ.

J Med Chem. 2015 Apr 23;58(8):3500-11. doi: 10.1021/acs.jmedchem.5b00032. Epub 2015 Apr 14.

PMID:
25799373
4.

Optimal interpretative strategy for preoperative parathyroid scintigraphy.

Bahador FM, Latifi HR, Grossman SJ, Oza UD, Xu H, Griffeth LK.

Clin Nucl Med. 2015 Feb;40(2):116-22. doi: 10.1097/RLU.0000000000000626.

PMID:
25525929
5.

In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist.

Zhou L, Dockens RC, Liu-Kreyche P, Grossman SJ, Iyer RA.

Drug Metab Dispos. 2012 Jun;40(6):1093-103. doi: 10.1124/dmd.111.043596. Epub 2012 Mar 1.

PMID:
22381334
6.

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor.

He K, Luettgen JM, Zhang D, He B, Grace JE Jr, Xin B, Pinto DJ, Wong PC, Knabb RM, Lam PY, Wexler RR, Grossman SJ.

Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):129-39. doi: 10.1007/s13318-011-0037-x. Epub 2011 Apr 2.

PMID:
21461793
7.

Tissue distribution and elimination of [14C]apixaban in rats.

Wang L, He K, Maxwell B, Grossman SJ, Tremaine LM, Humphreys WG, Zhang D.

Drug Metab Dispos. 2011 Feb;39(2):256-64. doi: 10.1124/dmd.110.036442. Epub 2010 Nov 11.

PMID:
21071521
8.

In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.

Wang L, Zhang D, Raghavan N, Yao M, Ma L, Frost CE, Maxwell BD, Chen SY, He K, Goosen TC, Humphreys WG, Grossman SJ.

Drug Metab Dispos. 2010 Mar;38(3):448-58. doi: 10.1124/dmd.109.029694. Epub 2009 Nov 25. Erratum in: Drug Metab Dispos. 2010 May;38(5):887. Frost, Charles A [corrected to Frost, Charles E].

PMID:
19940026
9.

Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.

Zhang D, He K, Raghavan N, Wang L, Mitroka J, Maxwell BD, Knabb RM, Frost C, Schuster A, Hao F, Gu Z, Humphreys WG, Grossman SJ.

Drug Metab Dispos. 2009 Aug;37(8):1738-48. doi: 10.1124/dmd.108.025981. Epub 2009 May 6.

PMID:
19420130
10.

N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations.

He K, Qian M, Wong H, Bai SA, He B, Brogdon B, Grace JE, Xin B, Wu J, Ren SX, Zeng H, Deng Y, Graden DM, Olah TV, Unger SE, Luettgen JM, Knabb RM, Pinto DJ, Lam PY, Duan J, Wexler RR, Decicco CP, Christ DD, Grossman SJ.

J Pharm Sci. 2008 Jul;97(7):2568-80.

PMID:
17914718
11.

Glucuronidation in the chimpanzee (Pan troglodytes): studies with acetaminophen, oestradiol and morphine.

Wong H, Grace JE Jr, Wright MR, Browning MR, Grossman SJ, Bai SA, Christ DD.

Xenobiotica. 2006 Dec;36(12):1178-90.

PMID:
17162465
12.

Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.

Wong H, Lehman-McKeeman LD, Grubb MF, Grossman SJ, Bhaskaran VM, Solon EG, Shen HS, Gerson RJ, Car BD, Zhao B, Gemzik B.

Toxicol Sci. 2005 Apr;84(2):232-42. Epub 2005 Jan 26.

PMID:
15673846
13.

The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.

Wong H, Grossman SJ, Bai SA, Diamond S, Wright MR, Grace JE Jr, Qian M, He K, Yeleswaram K, Christ DD.

Drug Metab Dispos. 2004 Dec;32(12):1359-69. Epub 2004 Aug 27.

PMID:
15333515
14.

Drug metabolites in safety testing.

Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossman SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA.

Toxicol Appl Pharmacol. 2002 Aug 1;182(3):188-96. Review.

PMID:
12229863
15.

Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.

Prahalada S, Rhodes L, Grossman SJ, Heggan D, Keenan KP, Cukierski MA, Hoe CM, Berman C, van Zwieten MJ.

Prostate. 1998 May 15;35(3):157-64.

PMID:
9582084
16.

Hepatotoxicity of an HIV protease inhibitor in dogs and rats.

Grossman SJ, Reinford N, Anderson C, Eydelloth RS, Alberts DW, Smith PF, Patrick DH.

Toxicol Appl Pharmacol. 1997 Sep;146(1):40-52.

PMID:
9299595
17.

Binge drinking, tobacco, and illicit drug use and involvement in college athletics. A survey of students at 140 American colleges.

Wechsler H, Davenport AE, Dowdall GW, Grossman SJ, Zanakos SI.

J Am Coll Health. 1997 Mar;45(5):195-200.

PMID:
9069676
18.

Acute cholecystitis detected on a Tc-99m sestamibi myocardial imaging.

Lamont AE, Joyce JM, Grossman SJ.

Clin Nucl Med. 1996 Nov;21(11):879. No abstract available.

PMID:
8922852
19.

Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.

Cribb AE, Nuss CE, Alberts DW, Lamphere DB, Grant DM, Grossman SJ, Spielberg SP.

Chem Res Toxicol. 1996 Mar;9(2):500-7.

PMID:
8839055
20.

Clinically unsuspected epiglottitis detected by indium-111-white blood cell scintigraphy.

Grabb BC, Joyce JM, Grossman SJ, Weinbaum DL.

J Nucl Med. 1996 Jan;37(1):76-7.

21.

The changing practice of nuclear medicine.

Brown RK, Grossman SJ, Locko RC, Lull RJ, Nagle CE, O'Mara RE, Sandler MP, Van Nostrand D.

J Nucl Med. 1995 Sep;36(9):30N-31N, 36N. No abstract available.

PMID:
7658243
22.

Altered biodistribution of Tc-99m HMDP on bone scintigraphy from recent intravenous iron therapy.

Forauer AR, Grossman SJ, Joyce JM.

Clin Nucl Med. 1994 Sep;19(9):817-8. No abstract available.

PMID:
7982320
23.

Multiple brown tumors in unsuspected primary hyperparathyroidism mimicking metastatic disease on radiograph and bone scan.

Joyce JM, Idea RJ, Grossman SJ, Liss RG, Lyons JB.

Clin Nucl Med. 1994 Jul;19(7):630-5. No abstract available.

PMID:
7924108
24.
25.

CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.

Grossman SJ, Herold EG, Drey JM, Alberts DW, Umbenhauer DR, Patrick DH, Nicoll-Griffith D, Chauret N, Yergey JA.

Drug Metab Dispos. 1993 Nov-Dec;21(6):1029-36.

PMID:
7905381
26.

Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).

Nicoll-Griffith DA, Chauret N, Yergey JA, Trimble LA, Favreau L, Zamboni R, Grossman SJ, Drey J, Herold E.

Drug Metab Dispos. 1993 Sep-Oct;21(5):861-7.

PMID:
7902249
27.
28.
29.

Clinical impact of magnetic resonance imaging in foot osteomyelitis.

Nigro ND, Bartynski WS, Grossman SJ, Kruljac S.

J Am Podiatr Med Assoc. 1992 Dec;82(12):603-15. Erratum in: J Am Podiatr Med Assoc 1993 Feb;83(2):86.

PMID:
1299726
30.

Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

Collier BD, Abdel-Nabi H, Doerr RJ, Harwood SJ, Olsen J, Kaplan EH, Winzelberg GG, Grossman SJ, Krag DN, Mitchell EP.

Radiology. 1992 Oct;185(1):179-86.

PMID:
1523304
31.

Enantioselective induction of peroxisomal proliferation in CD-1 mice by leukotriene antagonists.

Grossman SJ, DeLuca JG, Zamboni RJ, Keenan KP, Patrick DH, Herold EG, van Zwieten MJ, Zacchei AG.

Toxicol Appl Pharmacol. 1992 Oct;116(2):217-24.

PMID:
1412466
32.

Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate.

Tanaka K, Smith PF, Stromberg PC, Eydelloth RS, Herold EG, Grossman SJ, Frank JD, Hertzog PR, Soper KA, Keenan KP.

Toxicol Appl Pharmacol. 1992 Sep;116(1):71-7.

PMID:
1529455
33.

Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, MacDonald JS.

Eur Heart J. 1992 Jul;13 Suppl B:2-6. No abstract available.

PMID:
1644096
34.

Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.

Winzelberg GG, Grossman SJ, Rizk S, Joyce JM, Hill JB, Atkinson DP, Sudina K, Anderson K, McElwain D, Jones AM.

Cancer. 1992 Apr 1;69(7):1656-63.

PMID:
1551051
35.

Scrotal scintigraphy in testicular torsion.

Joyce JM, Grossman SJ.

Emerg Med Clin North Am. 1992 Feb;10(1):93-102. Review.

PMID:
1732099
36.

Risk-taking behavior of college students and social forces.

Canterbury RJ, Gressard CF, Vieweg WV, Grossman SJ, McKelway RB, Westerman PS.

Am J Drug Alcohol Abuse. 1992;18(2):213-22.

PMID:
1562017
37.

Thiobenzamide-induced hepatotoxicity: effects of substituents and route of administration on the nature and extent of liver injury.

Grossman SJ, Patrick DH, Kornbrust D, Smith PF, Herold EG, DeLuca JG, Zacchei AG.

Toxicol Appl Pharmacol. 1991 Dec;111(3):388-408.

PMID:
1746022
38.

Hepatobiliary imaging.

Grossman SJ, Joyce JM.

Emerg Med Clin North Am. 1991 Nov;9(4):853-74. Review.

PMID:
1915052
39.

Ventilation-perfusion scintigraphy.

McCabe JL, Grossman SJ, Joyce JM.

Emerg Med Clin North Am. 1991 Nov;9(4):805-25. Review.

PMID:
1915050
40.

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS.

J Pharmacol Exp Ther. 1991 Jun;257(3):1225-35.

PMID:
1904494
41.

Alcohol and cocaine use among first-year college students.

Canterbury RJ, Gressard CF, Vieweg WV, Grossman SJ, Westerman PS, McKelway RB.

South Med J. 1991 Jan;84(1):13-7, 21.

PMID:
1986420
42.

Alcohol abuse among college freshmen in Greek societies.

Canterbury RJ, Gressard CF, Vieweg WV, Grossman SJ, McKelway RB, Westerman PS.

Va Med Q. 1991 Summer;118(3):171-2. No abstract available.

PMID:
1868110
43.

Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat.

Smith PF, Grossman SJ, Gerson RJ, Gordon LR, Deluca JG, Majka JA, Wang RW, Germershausen JI, MacDonald JS.

Toxicol Pathol. 1991;19(3):197-205.

PMID:
1780636
44.
45.

External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor.

Clark RL, Antonello JM, Grossman SJ, Wise LD, Anderson C, Bagdon WJ, Prahalada S, MacDonald JS, Robertson RT.

Teratology. 1990 Jul;42(1):91-100.

PMID:
2168096
46.

Psychosocial inventory among first-year college students by patterns of alcohol use.

Canterbury RJ, Gressard CF, Vieweg WV, Grossman SJ, Westerman PS, McKelway RB.

Adv Alcohol Subst Abuse. 1990;9(3-4):1-11.

PMID:
2288299
47.

Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.

Grossman SJ, Jollow DJ.

J Pharmacol Exp Ther. 1988 Jan;244(1):118-25.

PMID:
3335994
48.
49.

Left ventricular diastolic filling and its association with age.

Miller TR, Grossman SJ, Schectman KB, Biello DR, Ludbrook PA, Ehsani AA.

Am J Cardiol. 1986 Sep 1;58(6):531-5.

PMID:
3751916
50.

Hydroxylamines and hemolytic anemia.

Jollow DJ, Grossman SJ, Harrison JH.

Adv Exp Med Biol. 1986;197:573-82. No abstract available.

PMID:
3766282

Supplemental Content

Loading ...
Support Center